Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Prostate cancer remains a significant concern in my practice, which is why I emphasize the importance of early detection. The American Cancer Society estimates there will be nearly 300,000 new cases ...

Dear G.K.: A PSA test is a simple and safe blood test, but the results may put a man onto a pathway that can lead to both benefit and harm, from which it is difficult to step off of. The goal of PSA ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

NEW YORK (Reuters Health) - The possible benefits and harms of prostate cancer screening have been hotly debated in recent years, but for the first time a new study tries to put a number on the ...

Prostate cancer screening was revolutionized in the early 1990s with the wide spread availability and FDA approval of PSA testing. PSA however is not specific for clinically significant prostate ...

EDITOR’S NOTE: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. When I learned that ...

CINCINNATI (WKRC) - Defense Secretary Lloyd Austin’s diagnosis of prostate cancer has specialists reminding everyone about the importance of early detection. But, many men are still not getting the ...

Duncan Sutcliffe from Worcester urges men over 50 to request annual PSA tests from their GP, highlighting early prostate cancer detection saves ...

CHICAGO—The American Urological Association (AUA) recommends that PSA testing should be offered to well-informed men aged 40 years and older who have a life expectancy of at least 10 years. This ...

(HealthDay News) — Many men in the control arm of a screening trial undergo prostate-specific antigen testing during 15 years of follow-up, according to a study published in the July issue of The ...